Silicone gel sheet dressing for sclerodermatous type chronic graft-versus-host-disease (cGVHD)

Systemic sclerosis is an autoimmune disease characterized by endothelial cell injury, fibroblast activation and immunological aberrations. Generalized form of the disease involves skin and other organs. Progressive sclerodermatous type cGVHD is the difficult type to treat. Immunosuppressors are the most commonly used treatment regimens. Topical silicone gel sheet (SGS) were first used in the treatment of burn wound and following their initial successes have begun to be used in the treatment of hypertrophic scars and keloids. To best of our knowledge, this is the first patient with extensive sclerodermatous type cGVHD in whom SGS was applied on to the skin of the antecubital region. After a six months application of SGS, the skin of this region was remarkably soft and thick compared to other regions of the arm. The result indicate that SGS may be an useful tool for the treatment of extensive sclerodermatous type cGVHD.

Yazar Dinçer S.L.
Kargi E.
Dinçer S.
Fitoz F.
Akan H.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/7528
Konu Başlıkları Dressing
Graft-versus-host-disease
Silicone
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
Dergi Adı Turkish Journal of Haematology
Dergi Cilt Bilgisi 21
Dergi Sayısı 2
Sayfalar 107 - 110
Yayın Yılı 2004
Eser Adı
[dc.title]
Silicone gel sheet dressing for sclerodermatous type chronic graft-versus-host-disease (cGVHD)
Yazar
[dc.contributor.author]
Dinçer S.L.
Yazar
[dc.contributor.author]
Kargi E.
Yazar
[dc.contributor.author]
Dinçer S.
Yazar
[dc.contributor.author]
Fitoz F.
Yazar
[dc.contributor.author]
Akan H.
Yayın Yılı
[dc.date.issued]
2004
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Systemic sclerosis is an autoimmune disease characterized by endothelial cell injury, fibroblast activation and immunological aberrations. Generalized form of the disease involves skin and other organs. Progressive sclerodermatous type cGVHD is the difficult type to treat. Immunosuppressors are the most commonly used treatment regimens. Topical silicone gel sheet (SGS) were first used in the treatment of burn wound and following their initial successes have begun to be used in the treatment of hypertrophic scars and keloids. To best of our knowledge, this is the first patient with extensive sclerodermatous type cGVHD in whom SGS was applied on to the skin of the antecubital region. After a six months application of SGS, the skin of this region was remarkably soft and thick compared to other regions of the arm. The result indicate that SGS may be an useful tool for the treatment of extensive sclerodermatous type cGVHD.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Dressing
Konu Başlıkları
[dc.subject]
Graft-versus-host-disease
Konu Başlıkları
[dc.subject]
Silicone
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
1300-7777
İlk Sayfa Sayısı
[dc.identifier.startpage]
107
Son Sayfa Sayısı
[dc.identifier.endpage]
110
Dergi Adı
[dc.relation.journal]
Turkish Journal of Haematology
Dergi Sayısı
[dc.identifier.issue]
2
Dergi Cilt Bilgisi
[dc.identifier.volume]
21
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/7528
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
11
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
08 Şubat 2024 00:18
Google Kontrol
Tıklayınız
treatment sclerodermatous extensive region disease patient knowledge applied keloids antecubital Systemic useful indicate result regions compared remarkably application months hypertrophic immunological Progressive organs involves Generalized aberrations activation fibroblast injury endothelial characterized autoimmune difficult Immunosuppressors successes
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms